Kessler R M, Mason N S, Votaw J R, De Paulis T, Clanton J A, Ansari M S, Schmidt D E, Manning R G, Bell R L
Department of Radiology, Vanderbilt University School of Medicine, Nashville, TN 37232.
Eur J Pharmacol. 1992 Nov 13;223(1):105-7. doi: 10.1016/0014-2999(92)90825-o.
[123I]Epidepride, a potent and selective dopamine D2 radioligand, was administered to a 27 year old normal male volunteer. Single photon tomography revealed that peak striatal uptake occurred at 4 h after injection with a striatal:cerebellar ratio of 7.8 rising to over 100 at 18 h post injection. Uptake above the levels seen in cerebellum was also noted in the thalamus, pituitary, hypothalamus and temporal lobe, particularly medially. Single photon tomography with [123I]epidepride allows visualization of extrastriatal dopamine D2 receptors in man.
[123I]表哌立登是一种强效且具有选择性的多巴胺D2放射性配体,将其给予一名27岁的正常男性志愿者。单光子断层扫描显示,纹状体摄取峰值在注射后4小时出现,纹状体与小脑的比值为7.8,在注射后18小时升至100以上。在丘脑、垂体、下丘脑和颞叶,特别是内侧,也观察到摄取高于小脑中的水平。用[123I]表哌立登进行单光子断层扫描可使人体纹状体以外的多巴胺D2受体可视化。